Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

A recent study highlights alarming health statistics among doctors in Gujarat, revealing that 20% are obese, 53% diabetic, and 24% hypertensive, raising concerns about their own health amid advocacy ...

The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — ...

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

If you’re living with diabetes, learn why you may be at greater risk for opioid use (and misuse) and what to do about it.

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

The Danish drugmaker reported last year that a late-stage study in people who don’t have diabetes showed that the daily pill led to an average weight loss of 15% over 68 weeks, a similar result ...

Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...

A daily diet pill has shown promising results in early trials, with participants losing an average of 13% of their body weight in 12 weeks compared to 6% in those taking the Wegovy injection.